Tolerance to pirprofen and preliminary efficacy trial in rheumatoid arthritis.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007596:Joints / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010666:Phenylpropionates / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D010919:Placebos; D011329:Prisoners; D011758:Pyrroles / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D010666:Phenylpropionates; D010919:Placebos; D011758:Pyrroles; D007213:Indomethacin